Prof. R.M. Luiten PhD publications

2020

• Böhm M., Kemp E. H., Metze D., Muresan A. M., Neufeld M., Luiten R. M., Ruck T. Alemtuzumab-induced halo naevus-like hypopigmentation – new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody Journal of the European Academy of Dermatology and Venereology 2020 [PubMed]
• Dijkgraaf Feline E., Matos Tiago R., Hoogenboezem Mark, Toebes Mireille, Vredevoogd David W., Mertz Marjolijn, van den Broek Bram, Song Ji-Ying, Teunissen Marcel B. M., Luiten Rosalie M., Beltman Joost B., Schumacher Ton N. Author Correction: Tissue patrol by resident memory CD8+ T cells in human skin (Nature Immunology, (2019), 20, 6, (756-764), 10.1038/s41590-019-0404-3) Nature immunology 2020;21 (6):696 [PubMed]
• Elshot Yannick S., Uitentuis S. E., Luiten R. M., Wolkerstorfer A., Bekkenk M. W. De schemerzone in de diagnostiek van melanocytpathologie Nederlands tijdschrift voor dermatologie en venereologie 2020;30 (8):12-14
• Tio Darryl, Willemsen Marcella, Krebbers Gabrielle, Kasiem Fazira R., Hoekzema Rick, van Doorn Remco, Bekkenk Marcel W., Luiten Rosalie M. Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma American Journal of dermatopathology 2020;42 (8):625-627 [PubMed]
• Roekevisch E., Szegedi K., Hack D. P., Schram M. E., Res P. C. J. M., Bos J. D., Leeflang M. M. G., Luiten R. M., Kezic S., Spuls P. I., Middelkamp-Hup M. A. Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients Journal of the European Academy of Dermatology and Venereology 2020;34 (7):1545-1554 [PubMed]
• Uitentuis S E, Willemsen K J, Lommerts J E, Komen L, Tjin E P M, Bekkenk M W, Wolkerstorfer A, Luiten R M Impact of graft cell density and viability on repigmentation upon noncultured autologous cell suspension transplantation in vitiligo and piebaldism Clinical and experimental dermatology 2020;45 (7):907-908 [PubMed]
• Ruijter C. G. H., Ouwerkerk W., Jaspars E. H., van Doorn R., Luiten R. M., Bekkenk M. W., Tio D. C. K. S. Incidence and outcome of Spitzoid tumour of unknown malignant potential (STUMP): an analysis of cases in the Netherlands from 1999 to 2014 British journal of dermatology 2020 [PubMed]
• Willemsen Marcella, Luiten Rosalie M., Teunissen Marcel B. M. Instant isolation of highly purified human melanocytes from freshly prepared epidermal cell suspensions Pigment cell & melanoma research 2020;33 (5):763-766 [PubMed]
• Dijkgraaf Feline E., Toebes Mireille, Hoogenboezem Mark, Mertz Marjolijn, Vredevoogd David W., Matos Tiago R., Teunissen Marcel B. M., Luiten Rosalie M., Schumacher Ton N. Labeling and tracking of immune cells in ex vivo human skin Nature protocols 2020 [PubMed]
• Tio Darryl C. K. S. Lentigo maligna: Clinical management and histopathological diagnosis 2020. 226p. ISBN 9789464021479. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Luiten Rosalie M., Hoekzema Richard; Co-supervisors: Bekkenk Marcel W., van Montfrans Gert A.)
• Uitentuis Sanne E. Light and color: Imaging, outcome measures and treatment in vitiligo 2020. 219p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Luiten Rosalie M., de Rie Menno A.; Co-supervisors: Wolkerstorfer Albert, Bekkenk Marcel W.)
• Narayan V. S., Uitentuis S. E., Luiten R. M., Bekkenk M. W., Wolkerstorfer A. Patients’ perspective on current treatments and demand for novel treatments in vitiligo Journal of the European Academy of Dermatology and Venereology 2020 [PubMed]
• Willemsen Marcella, Melief Cornelis J. M., Bekkenk Marcel W., Luiten Rosalie M. Targeting the PD-1/PD-L1 Axis in Human Vitiligo Frontiers in immunology 2020;11 [PubMed]
• Uitentuis S. E., Heilmann M. N., Verdaasdonk R. M., Bae J. M., Luiten R. M., Wolkerstorfer A., Bekkenk M. W. Ultraviolet photography in vitiligo: image quality, validity and reliability Journal of the European Academy of Dermatology and Venereology 2020;34 (7):1590-1594 [PubMed]
• Narayan Vidhya S., Luiten R. M., Wolkerstorfer A., Bekkenk M. W. Vitiligo: Therapie nu en in de toekomst Nederlands tijdschrift voor dermatologie en venereologie 2020;30 (8):9-11
• Matos Tiago R., Willemsen M., Bekkenk M. W., Bakker W. J., Luiten R. M. Weefselresidente t-geheugencellen in vitiligo en melanoom Nederlands tijdschrift voor dermatologie en venereologie 2020;30 (8):6-8

2019

• Ouwerkerk Wouter, van den Berg Mirjam, van der Niet Sanne, Limpens Jacqueline, Luiten Rosalie M. Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review Melanoma research 2019;29 (5):453-464 [PubMed]
• Tio Darryl, Kasiem Fazira R., Willemsen Marcella, van Doorn Remco, van der Werf Nienke, Hoekzema Rick, Luiten Rosalie M., Bekkenk Marcel W. Expression of cancer/testis antigens in cutaneous melanoma: a systematic review Melanoma research 2019;29 (4):349-357 [PubMed]
• Kammeyer Arthur, Willemsen Karin J., Ouwerkerk Wouter, Bakker Walbert J., Ratsma Danielle, Pronk Sebas D., Smit Nico P. M., Luiten Rosalie M. Mechanism of action of 4-substituted phenols to induce vitiligo and antimelanoma immunity Pigment cell & melanoma research 2019;32 (4):540-552 [PubMed]
• Eby Jonathan M., Smith Angela R., Riley Timothy P., Cosgrove Cormac, Ankney Christian M., Henning Steven W., Paulos Chrystal M., Garrett-Mayer Elizabeth, Luiten Rosalie M., Nishimura Michael I., Baker Brian M., le Poole I. Caroline Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells Pigment cell & melanoma research 2019;32 (1):68-78 [PubMed]
• Willemsen Marcella, Linkutė Rugile, Luiten Rosalie M., Matos Tiago R. Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma Pigment cell & melanoma research 2019;32 (5):612-622 [PubMed]
• Vrijman C., Willemsen K. J., Tjin E. P. M., Kammeyer A., van den Boorn J. G., van der Veen J. P. W., Jungbauer F. H. W., Kardaun S. H., Luiten R. M. T-cell responses against 4-tert-butylphenol-exposed pigmented cells in a patient with occupational vitiligo British journal of dermatology 2019;181 (2):387-388 [PubMed]
• Dijkgraaf Feline E., Matos Tiago R., Hoogenboezem Mark, Toebes Mireille, Vredevoogd David W., Mertz Marjolijn, van den Broek Bram, Song Ji-Ying, Teunissen Marcel B. M., Luiten Rosalie M., Beltman Joost B., Schumacher Ton N. Tissue patrol by resident memory CD8+ T cells in human skin Nature immunology 2019;20 (6):756-764 [PubMed]

2018

• Teulings Hansje-Eva, Tjin Esther P. M., Willemsen Karina J., van der Kleij Stephanie, Meulen Sylvia ter, Kemp E. Helen, Krebbers Gabrielle, van Noesel Carel J. M., Franken Cornelis L. M. C., Drijfhout Jan W., Melief Cornelis J. M., Nieuweboer-Krobotova Ludmila, Nieweg Omgo E., van der Hage Jos A., van der Veen J. P. Wietze, Relyveld Germaine N., Luiten Rosalie M. Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial Oncoimmunology 2018;7 (4) [PubMed]
• Lommerts Janny E. Coloring the spots: Diagnosis, measurement instruments and treatment in vitiligo 2018. ISBN 9789462999909. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Rie M. A., Luiten R. M.; Co-supervisors: Bekkenk M. W., Wolkerstorfer A.)
• Szegedi Krisztina, van Lier Amanda, Res Pieter C., Chielie Saskia, Bos Jan D., Kezic Sanja, Middelkamp-Hup Maritza A., Luiten Rosalie M. House Dust Mite allergens Der f and Der p induce IL-31 production by blood derived T cells from Atopic Dermatitis patients Experimental dermatology 2018;27 (4):393-395 [PubMed]

2017

• Lommerts J. E., Meesters A. A., Komen L., Bekkenk M. W., de Rie M. A., Luiten R. M., Wolkerstorfer A. Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO2 laser recipient-site preparations British journal of dermatology 2017;177 (5):1293-1298 [PubMed]
• Jessurun Charissa A. C., Vos Julien A. M., Limpens Jacqueline, Luiten Rosalie M. Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review Frontiers in oncology 2017;7:233 [PubMed]
• Komen Lisa, Vrijman Charlotte, Prinsen Cecilia A. C., van der Veen J. P. Wietze, Luiten Rosalie M., Wolkerstorfer Albert Optimising size and depth of punch grafts in autologous transplantation of vitiligo and piebaldism: a randomised controlled trial Journal of dermatological treatment 2017;28 (1):86-91 [PubMed]
• Teulings H. E., Lommerts J. E., Wolkerstorfer A., Nieuweboer-Krobotova L., Luiten R. M., Bekkenk M. W., van der Veen J. P. W. Vitiligo-like depigmentations as the first sign of melanoma: a retrospective case series from a tertiary vitiligo centre British journal of dermatology 2017;176 (2):503-506 [PubMed]

2016

• Luiten R. M. De licht-en schaduwzijde van huidpigment. Nederlands tijdschrift voor dermatologie en venereologie 2016;26 (2):105-109
• Klarquist Jared, Eby Jonathan M., Henning Steven W., Li Mingli, Wainwright Derek A., Westerhof Wiete, Luiten Rosalie M., Nishimura Michael I., Le Poole I. Caroline Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin Pigment cell & melanoma research 2016;29 (3):379-384 [PubMed]
• Jin Ying, Andersen Genevieve, Yorgov Daniel, Ferrara Tracey M., Ben Songtao, Brownson Kelly M., Holland Paulene J., Birlea Stanca A., Siebert Janet, Hartmann Anke, Lienert Anne, van Geel Nanja, Lambert Jo, Luiten Rosalie M., Wolkerstorfer Albert, Wietze van der Veen J. P., Bennett Dorothy C., Taïeb Alain, Ezzedine Khaled, Kemp E. Helen, Gawkrodger David J., Weetman Anthony P., Kõks Sulev, Prans Ele, Kingo Külli, Karelson Maire, Wallace Margaret R., McCormack Wayne T., Overbeck Andreas, Moretti Silvia, Colucci Roberta, Picardo Mauro, Silverberg Nanette B., Olsson Mats, Valle Yan, Korobko Igor, Böhm Markus, Lim Henry W., Hamzavi Iltefat, Zhou Li, Mi Qing-Sheng, Fain Pamela R., Santorico Stephanie A., Spritz Richard A. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants Nature genetics 2016;48 (11):1418-1424 [PubMed]
• van den Boorn Jasper G., Jakobs Christopher, Hagen Christian, Renn Marcel, Luiten Rosalie M., Melief Cornelis J. M., Tüting Thomas, Garbi Natalio, Hartmann Gunther, Hornung Veit Inflammasome-Dependent Induction of Adaptive NK Cell Memory Immunity 2016;44 (6):1406-1421 [PubMed]
• Lommerts Janny E., Teulings Hansje-Eva, Ezzedine Khaled, van Geel Nanja, Hartmann Anke, Speeckaert Reinhart, Spuls Phyllis I., Wolkerstorfer Albert, Luiten Rosalie M., Bekkenk Marcel W. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field Journal of the American Academy of Dermatology 2016;75 (6):1198-1204 [PubMed]
• Teulings H. E., Ceylan E., Overkamp M., Vrijman C., Bos J. D., Nijsten T. E., Wolkerstorfer A., Luiten R. M., van der Veen J. P. W. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years British journal of dermatology 2016;175 (4):821-824 [PubMed]
• Luiten R. M. Van donker naar licht Nederlands tijdschrift voor dermatologie en venereologie 2016;26 (5):259-262
• Luiten R. M. Vitiligo en de relatie tot melanoom Nederlands tijdschrift voor dermatologie en venereologie 2016;26 (3):157-159

2015

• Komen Lisa, Vrijman Charlotte, Tjin Esther P. M., Krebbers Gabrielle, de Rie Menno A., Luiten Rosalie M., van der Veen J. P. Wietze, Wolkerstorfer Albert Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study Journal of the American Academy of Dermatology 2015;73 (1):170-172 [PubMed]
• Szegedi K., Lutter R., Res P. C., Bos J. D., Luiten R. M., Kezic S., Middelkamp-Hup M. A. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin Journal of the European Academy of Dermatology and Venereology 2015;29 (11):2136-2144 [PubMed]
• Vrijman Charlotte Evaluation and treatment of vitiligo 2015. 217p. ISBN 9789461825438. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Luiten R. M., Bos J. D.; Co-supervisors: Wolkerstorfer A., van der Veen J. P. W.)
• Teulings Hansje-Eva Melanoma versus vitiligo: Clinical aspects and implications for immunotherapy 2015. 204p. ISBN 9789461825865. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Luiten R. M.; Co-supervisors: Bos J. D., van der Veen J. P. W.)
• Kammeyer A., Luiten R. M. Oxidation events and skin aging Ageing research reviews 2015;21:16-29 [PubMed]
• Kroon Maria Wilhelmina Pigmented skin disorders: Evaluation and treatment 2015. 184p. ISBN 9789090288611. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bos Jan D., Luiten R. M.; Co-supervisors: Wolkerstorfer A., van der Veen J. P. W.)
• Teulings Hansje-Eva, Limpens Jacqueline, Jansen Sophia N., Zwinderman Aeilko H., Reitsma Johannes B., Spuls Phyllis I., Luiten Rosalie M. Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis Journal of clinical oncology 2015;33 (7):773-781 [PubMed]

2014

• Webb Kirsten C., Eby Jonathan M., Hariharan Vidhya, Hernandez Claudia, Luiten Rosalie M., Le Poole I. Caroline Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo Experimental dermatology 2014;23 (8):529-533 [PubMed]
• Tjin Esther P. M., Krebbers Gabrielle, Meijlink Kimberley J., van de Kasteele Willeke, Rosenberg Efraim H., Sanders Joyce, Nederlof Petra M., van de Wiel Bart A., Haanen John B. A. G., Melief Cornelis J. M., Vyth-Dreese Florry A., Luiten Rosalie M. Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy Cancer immunology research 2014;2 (6):538-546 [PubMed]
• Teulings Hansje-Eva, Willemsen Karin J., Glykofridis Iris, Krebbers Gabrielle, Komen Lisa, Kroon Marije W., Kemp E. Helen, Wolkerstorfer Albert, van der Veen J. P. Wietze, Luiten Rosalie M., Tjin Esther P. M. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo Pigment cell & melanoma research 2014;27 (6):1086-1096 [PubMed]
• Tjin Esther P. M., Luiten Rosalie M. Tumor-infiltrating T-cells: important players in clinical outcome of advanced melanoma patients Oncoimmunology 2014;3 (9):e954862 [PubMed]

2013

• Teulings H. E., Overkamp M., Ceylan E., Nieuweboer-Krobotova L., Bos J. D., Nijsten T., Wolkerstorfer A. W., Luiten R. M., van der Veen J. P. W. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners British journal of dermatology 2013;168 (1):162-171 [PubMed]
• Kroon Marije W., Vrijman Charlotte, Chandeck Charlotte, Wind Bas S., Wolkerstorfer Albert, Luiten Rosalie M., Bos Jan D., Geskus Ronald B., van Trotsenburg Paul, van der Veen J. P. Wietze High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo Hormone research in paediatrics 2013;79 (3):137-144 [PubMed]
• Kroon M. W., Kemp E. Helen, Wind B. S., Krebbers G., Bos J. D., Gawkrodger D. J., Wolkerstorfer A., van der Veen J. P. Wietze, Luiten R. M. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo Journal of the European Academy of Dermatology and Venereology 2013;27 (9):1172-1175 [PubMed]
• Vrijman C., Hosseinpour D., Bakker J. G., Wolkerstorfer A., Bos J. D., van der Veen J. P. W., Luiten R. M. Provoking factors, including chemicals, in Dutch patients with vitiligo British journal of dermatology 2013;168 (5):1003-1011 [PubMed]
• Teulings H. E., Tjin E. P. M., Willemsen K. J., Krebbers G., van Noesel C. J., Kemp E. H., Nieuweboer-Krobotova L., van der Veen J. P. W., Luiten R. M. Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis British journal of dermatology 2013;168 (4):733-738 [PubMed]

2012

• Jin Ying, Birlea Stanca A., Fain Pamela R., Ferrara Tracey M., Ben Songtao, Riccardi Sheri L., Cole Joanne B., Gowan Katherine, Holland Paulene J., Bennett Dorothy C., Luiten Rosalie M., Wolkerstorfer Albert, van der Veen J. P. Wietze, Hartmann Anke, Eichner Saskia, Schuler Gerold, van Geel Nanja, Lambert Jo, Kemp E. Helen, Gawkrodger David J., Weetman Anthony P., Taïeb Alain, Jouary Thomas, Ezzedine Khaled, Wallace Margaret R., McCormack Wayne T., Picardo Mauro, Leone Giovanni, Overbeck Andreas, Silverberg Nanette B., Spritz Richard A. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo Nature genetics 2012;44 (6):676-U94 [PubMed]
• Szegedi Krisztina, Kremer Andreas E., Kezic Sanja, Teunissen Marcel B. M., Bos Jan D., Luiten Rosalie M., Res Pieter C., Middelkamp-Hup Maritza A. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin Experimental dermatology 2012;21 (6):431-436 [PubMed]
• Stroobant Vincent, Demotte Nathalie, Luiten Rosalie M., Leonhardt Ralf M., Cresswell Peter, Bonehill Aude, Michaux Alexandre, Ma Wenbin, Mulder Arend, van den Eynde Benoît J., van der Bruggen Pierre, Vigneron Nathalie Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells European journal of immunology 2012;42 (6):1417-1428 [PubMed]
• van Geel Nanja, Speeckaert Reinhart, Mollet Ilse, de Schepper Sofie, de Wolf Julie, Tjin Esther P. M., Luiten Rosalie M., Lambert Jo, Brochez Lieve In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial Pigment cell & melanoma research 2012;25 (1):57-65 [PubMed]
• Kroon M. W., Joore I. C. K. W., Wind B. S., Leloup M. A. C., Wolkerstorfer A., Luiten R. M., Bos J. D., Geskus R. B., van der Veen J. P. W. Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo British journal of dermatology 2012;166 (3):532-538 [PubMed]
• Weder P., Schumacher T. N. M., Spits H., Luiten R. M. Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes. Results in immunology 2012;17:88-96
• Vrijman C., Kroon M. W., Limpens J., Leeflang M. M. G., Luiten R. M., van der Veen J. P. W., Wolkerstorfer A., Spuls P. I. The prevalence of thyroid disease in patients with vitiligo: a systematic review British journal of dermatology 2012;167 (6):1224-1235 [PubMed]

2011

• Speeckaert Reinhart, van Geel Nanja, Luiten Rosalie M., van Gele Mireille, Speeckaert Marijn, Lambert Jo, Vermaelen Karim, Tjin Esther P. M., Brochez Lieve Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma Anticancer research 2011;31 (11):3697-3703 [PubMed]
• van den Boorn Jasper G., Melief Cornelis J., Luiten Rosalie M. Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity Pigment cell & melanoma research 2011;24 (4):673-679 [PubMed]
• van den Boorn Jasper G., Picavet Daisy I., van Swieten Paul F., van Veen Henk A., Konijnenberg Debby, van Veelen Peter A., van Capel Toni, Jong Esther C. de, Reits Eric A., Drijfhout Jan W., Bos Jan D., Melief Cornelis J. M., Luiten Rosalie M. Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy Journal of investigative dermatology 2011;131 (6):1240-1251 [PubMed]
• Tjin Esther P. M., Konijnenberg Debby, Krebbers Gabrielle, Mallo Henk, Drijfhout Jan W., Franken Kees L. M. C., van der Horst Chantal M. A. M., Bos Jan D., Nieweg Omgo E., Kroon Bin B. R., Haanen John B. A. G., Melief Cornelis J. M., Vyth-Dreese Florry A., Luiten Rosalie M. T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy Clinical cancer research 2011;17 (17):5736-5747 [PubMed]

2010

• van den Boorn Jasper G., Konijnenberg Debby, Tjin Esther P. M., Picavet Daisy I., Meeuwenoord Nico J., Filippov Dmitri V., van der Veen J. P. Wietze, Bos Jan D., Melief Cornelis J. M., Luiten Rosalie M. Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG PLoS ONE 2010;5 (5):e10626 [PubMed]
• van Geel Nanny A. C., Mollet Ilse G., de Schepper Sofie, Tjin Esther P. M., Vermaelen Karim, Clark Rachael A., Kupper Thomas S., Luiten Rosalie M., Lambert Jo First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi Pigment cell & melanoma research 2010;23 (3):375-384 [PubMed]
• van den Boorn Jasper G. Vitiligo pathogenesis and immunotherapy of melanoma 2010. 182p. ISBN 9789090371227. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bos J. D., Melief C. J. M.; Co-supervisor: Luiten R. M.)

2009

• van den Boorn Jasper G., Konijnenberg Debby, Dellemijn Trees A. M., van der Veen J. P. Wietze, Bos Jan D., Melief Cornelis J. M., Vyth-Dreese Florry A., Luiten Rosalie M. Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients Journal of investigative dermatology 2009;129 (9):2220-2232 [PubMed]
• Bos Jan D., Luiten Rosalie M. Skin immune system Cancer treatment and research 2009;146:45-62 [PubMed]

2008

• Le Poole I. Caroline, Luiten Rosalie M. Autoimmune etiology of generalized vitiligo Current directions in autoimmunity 2008;10:227-243 [PubMed]
• Schallreuter K. U., Bahadoran P., Picardo M., Slominski A., Elassiuty Y. E., Kemp E. H., Giachino C., Liu J. B., Luiten R. M., Lambe T., Le Poole I. C., Dammak I., Onay H., Zmijewski M. A., Dell'anna M. L., Zeegers M. P., Cornall R. J., Paus R., Ortonne J. P., Westerhof W. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Experimental dermatology 2008;17 (2):139-40; discussion 141-60 [PubMed]

2006

• Reits Eric A., Hodge James W., Herberts Carla A., Groothuis Tom A., Chakraborty Mala, Wansley Elizabeth K., Camphausen Kevin, Luiten Rosalie M., de Ru Arnold H., Neijssen Joost, Griekspoor Alexander, Mesman Elly, Verreck Frank A., Spits Hergen, Schlom Jeffrey, van Veelen Peter, Neefjes Jacques J. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy Journal of experimental medicine 2006;203 (5):1259-1271 [PubMed]
• van den Boorn Jasper G., Le Poole I. Caroline, Luiten Rosalie M. T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity International reviews of immunology 2006;25 (3-4):235-258 [PubMed]
• Oyarbide-Valencia Kepa, van den Boorn Jasper G., Denman Cecele J., Li Mingli, Carlson Jeremy M., Hernandez Claudia, Nishimura Michael I., Das Pranab K., Luiten Rosalie M., Le Poole I. Caroline Therapeutic implications of autoimmune vitiligo T cells Autoimmunity reviews 2006;5 (7):486-492 [PubMed]
• Luiten R. M. Vitiligo bij melanoom: een gunstig teken Nederlands tijdschrift voor oncologie 2006;3 (6):224-230

2005

• Luiten Rosalie M., Kueter Esther W. M., Mooi Wolter, Gallee Maarten P. W., Rankin Elaine M., Gerritsen Winald R., Clift Shirley M., Nooijen Willem J., Weder Pauline, van de Kasteele Willeke F., Sein Johan, van den Berk Paul C. M., Nieweg Omgo E., Berns Anton M., Spits Hergen, de Gast Gijsbert C. Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients Journal of clinical oncology 2005;23 (35):8978-8991 [PubMed]

2004

• Verra Natascha C. V., Jorritsma Annelies, Weijer Kees, Ruizendaal Janneke J., Voordouw Arie, Weder Pauline, Hooijberg Erik, Schumacher Ton N. M., Haanen John B. A. G., Spits Hergen, Luiten Rosalie M. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice Cancer research 2004;64 (6):2153-2161 [PubMed]

2003

• Luiten Rosalie M., Péne Jérome, Yssel Hans, Spits Hergen Ectopic hTERT expression extends the life span of human CD4(+) helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis Blood 2003;101 (11):4512-4519 [PubMed]
• Roth Alexander, Yssel Hans, Pene Jerome, Chavez Elizabeth A., Schertzer Mike, Lansdorp Peter M., Spits Hergen, Luiten Rosalie M. Telomerase levels control the lifespan of human T lymphocytes Blood 2003;102 (3):849-857 [PubMed]

2000

• Luiten R., van der Bruggen P. A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes Tissue antigens 2000;55 (2):149-152 [PubMed]
• Luiten R. M., Demotte N., Tine J., van der Bruggen P. A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules Tissue antigens 2000;56 (1):77-81 [PubMed]

1999

• Chaux P., Luiten R., Demotte N., Vantomme V., Stroobant V., Traversari C., Russo V., Schultz E., Cornelis G. R., Boon T., van der Bruggen P. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1 Journal of immunology (Baltimore, Md. 1999;163 (5):2928-2936 [PubMed]
• Chaux P., Vantomme V., Stroobant V., Thielemans K., Corthals J., Luiten R., Eggermont A. M., Boon T., van der Bruggen P. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes Journal of experimental medicine 1999;189 (5):767-778 [PubMed]

1997

• Luiten R. M., Warnaar S. O., Sanborn D., Lamers C. H., Bolhuis R. L., Litvinov S. V., Zurawski V. R., Coney L. R. Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients Journal of immunotherapy (Hagerstown, Md. 1997;20 (6):496-504 [PubMed]
• Luiten R. M., Warnaar S. O., Schuurman J., Pasmans S. G., Latour S., Daëron M., Fleuren G. J., Litvinov S. V. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells Human antibodies 1997;8 (4):169-180 [PubMed]

1996

• Luiten R. M., Coney L. R., Fleuren G. J., Warnaar S. O., Litvinov S. V. Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma British journal of cancer 1996;74 (5):735-744 [PubMed]
• Luiten R. M., Fleuren G. J., Warnaar S. O., Litvinov S. V. Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen Laboratory investigation; a journal of technical methods and pathology 1996;74 (2):467-475 [PubMed]

1991

• de Koster H. S., Kenter M. J., D'Amaro J., Luiten R. M., Schroeijers W. E., Giphart M. J., Termijtelen A. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules Immunogenetics 1991;34 (1):12-22 [PubMed]